Potential Late Effect of Gonadotropin-Releasing Hormone Agonists in Combination With Chemotherapy for Early Breast Cancer

被引：3
|
作者：
Saloustros, Emmanouil [1 ]
Stratakis, Constantine A. [1 ]
机构：
[1] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 26期
关键词：
RANDOMIZED-TRIAL; OVARIAN-FUNCTION; TRIPTORELIN; PREVENTION; MENOPAUSE;
D O I：
10.1200/JCO.2012.42.6197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3311 / 3312
页数：3
相关论文
共 50 条
  • [1] Potential Late Effect of Gonadotropin-Releasing Hormone Agonists in Combination With Chemotherapy for Early Breast Cancer Reply
    Munster, Pamela N.
    Moore, Amy P.
    Ismail-Khan, Roohi
    Cox, Charles E.
    Lacevic, Mensura
    Gross-King, Margaret
    Xu, Ping
    Carter, W. Bradford
    Minton, Susan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3312 - 3313
  • [2] Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
    Abdel-Razeq, Hikmat
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4273 - 4282
  • [3] Emerging gonadotropin-releasing hormone agonists
    Beyer, Daniel Alexander
    Amari, Feriel
    Thill, Marc
    Schultze-Mosgau, Askan
    Al-Hasani, Safaa
    Diedrich, Klaus
    Griesinger, Georg
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (02) : 323 - 340
  • [4] Gonadotropin-Releasing Hormone Agonists for the Preservation of Ovarian Function During Chemotherapy
    Tomao, Federica
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3311
  • [5] Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis
    Li, Zhen-Yu
    Dong, Ying-Li
    Cao, Xiao-Zhong
    Ren, Sha-Sha
    Zhang, Zhen
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2022, 29 (09): : 1093 - 1100
  • [6] Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists
    Hickman, Lisa C.
    Valentine, Lindsey N.
    Falcone, Tommaso
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (04) : 415 - 422
  • [7] Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
    Poggio, Francesca
    Lambertini, Matteo
    Bighin, Claudia
    Conte, Benedetta
    Blondeaux, Eva
    D'Alonzo, Alessia
    Dellepiane, Chiara
    Buzzatti, Giulia
    Molinelli, Chiara
    Boccardo, Francesco
    Del Mastro, Lucia
    CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
  • [8] Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy
    Poggio, Francesca
    Conte, Benedetta
    Lambertini, Matteo
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 245 - 246
  • [9] The Protective Effects of Gonadotropin-releasing Hormone Agonist on Ovarian Functions in Breast Cancer Patients Receiving Chemotherapy
    Wang, Chen
    Yu, Xing-Fei
    DISCOVERY MEDICINE, 2018, 25 (135) : 7 - 11
  • [10] Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain
    Turner, N. H.
    Partridge, A.
    Sanna, G.
    Di Leo, A.
    Biganzoli, L.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2224 - 2235
12345